EGFR and lung carcinoma: Therefore, although tumors expressing this mutant oncogene are clearly dependent on its sustained expression for survival, these findings suggest that additional genetic/epigenetic alterations cooperate with mutant EGFR, activating/disrupting genes that “modify” tumorigenic capacity in lung cancer development (Figure 2).